Friedrich Stölzel
Friedrich Stölzel
Verified email at
Cited by
Cited by
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ...
Leukemia 29 (10), 2062-2068, 2015
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M Von Bonin, F Stölzel, A Goedecke, K Richter, N Wuschek, K Hölig, ...
Bone marrow transplantation 43 (3), 245-251, 2009
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting …
C Röllig, M Bornhäuser, C Thiede, F Taube, M Kramer, B Mohr, W Aulitzky, ...
Journal of clinical oncology 29 (20), 2758-2765, 2011
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
F Kroschinsky, F Stölzel, S von Bonin, G Beutel, M Kochanek, M Kiehl, ...
Critical Care 21 (1), 1-11, 2017
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
C Röllig, C Thiede, M Gramatzki, W Aulitzky, H Bodenstein, M Bornhäuser, ...
Blood, The Journal of the American Society of Hematology 116 (6), 971-978, 2010
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
S Göllner, T Oellerich, S Agrawal-Singh, T Schenk, HU Klein, C Rohde, ...
Nature medicine 23 (1), 69-78, 2017
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ...
Nature medicine 24 (3), 282-291, 2018
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2 …
U Platzbecker, JM Middeke, K Sockel, R Herbst, D Wolf, CD Baldus, ...
The Lancet Oncology 19 (12), 1668-1679, 2018
18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia
F Stölzel, C Röllig, J Radke, B Mohr, U Platzbecker, M Bornhäuser, ...
Haematologica 96 (10), 1552, 2011
Mesenchymal stromal cells for treatment of acute steroid‐refractory graft versus host disease: clinical responses and long‐term outcome
F von Dalowski, M Kramer, M Wermke, R Wehner, C Röllig, N Alakel, ...
Stem Cells 34 (2), 357-366, 2016
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis
T Herold, KH Metzeler, S Vosberg, L Hartmann, C Röllig, F Stölzel, ...
Blood, The Journal of the American Society of Hematology 124 (8), 1304-1311, 2014
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia
T Bochtler, F Stölzel, CE Heilig, C Kunz, B Mohr, A Jauch, JWG Janssen, ...
Journal of clinical oncology 31 (31), 3898-3905, 2013
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront …
C Röllig, M Bornhäuser, M Kramer, C Thiede, AD Ho, A Krämer, ...
Hematology, 2011
Karyotype complexity and prognosis in acute myeloid leukemia
F Stölzel, B Mohr, M Kramer, U Oelschlägel, T Bochtler, WE Berdel, ...
Blood cancer journal 6 (1), e386-e386, 2016
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial
M Schaich, S Parmentier, M Kramer, T Illmer, F Stölzel, C Röllig, C Thiede, ...
Journal of clinical oncology 31 (17), 2094-2102, 2013
Outcome of patients with abnl (17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
JM Middeke, M Fang, JJ Cornelissen, B Mohr, FR Appelbaum, M Stadler, ...
Blood, The Journal of the American Society of Hematology 123 (19), 2960-2967, 2014
TP53 mutation in patients with high‐risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation
JM Middeke, S Herold, E Rücker‐Braun, WE Berdel, M Stelljes, ...
British journal of haematology 172 (6), 914-922, 2016
Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells
F Stölzel, C Steudel, U Oelschlägel, B Mohr, S Koch, G Ehninger, ...
Annals of hematology 89 (7), 653-662, 2010
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic …
F Stölzel, K Hackmann, F Kuithan, B Mohr, M Füssel, U Oelschlägel, ...
Transplantation 93 (7), 744-749, 2012
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia
D Ovcharenko, F Stölzel, D Poitz, F Fierro, M Schaich, A Neubauer, ...
Experimental hematology 39 (10), 1030-1042. e7, 2011
The system can't perform the operation now. Try again later.
Articles 1–20